Centene (CNC) is a publicly traded Healthcare sector company. As of August 19, 2026, CNC trades at $65.50 with a market cap of $31.82B and a P/E ratio of -6.34. CNC moved +1.32% today. Year to date, CNC is +58.49%; over the trailing twelve months it is +124.97%. Its 52-week range spans $25.08 to $69.36. Analyst consensus is buy with an average price target of $73.00. Rallies surfaces CNC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
16 analysts cover CNC: 0 strong buy, 7 buy, 9 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $73.00.
| Metric | Value |
|---|---|
| Price | $65.50 |
| Market Cap | $31.82B |
| P/E Ratio | -6.34 |
| EPS | $-10.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $69.36 |
| 52-Week Low | $25.08 |
| Volume | 2.30M |
| Avg Volume | 0 |
| Revenue (TTM) | $202.94B |
| Net Income | $-5.11B |
| Gross Margin | 7.97% |
16 analysts cover CNC: 0 strong buy, 7 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $73.00.